Isabelle Vigon

1.9k total citations · 1 hit paper
23 papers, 1.4k citations indexed

About

Isabelle Vigon is a scholar working on Hematology, Molecular Biology and Immunology. According to data from OpenAlex, Isabelle Vigon has authored 23 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 10 papers in Molecular Biology and 9 papers in Immunology. Recurrent topics in Isabelle Vigon's work include Acute Myeloid Leukemia Research (8 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Immune Cell Function and Interaction (5 papers). Isabelle Vigon is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Immune Cell Function and Interaction (5 papers). Isabelle Vigon collaborates with scholars based in France, Italy and Belgium. Isabelle Vigon's co-authors include Michèle Souyri, Jean‐Paul Mornon, P Tambourin, Fabrice Wendling, M. T. Mitjavila, Serge Fichelson, Sylvie Gisselbrecht, Isabelle Callebaut, Paul‐Henri Roméo and Vincent Mignotte and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Blood.

In The Last Decade

Isabelle Vigon

23 papers receiving 1.4k citations

Hit Papers

Molecular cloning and characterization of MPL, the human ... 1992 2026 2003 2014 1992 100 200 300 400

Peers

Isabelle Vigon
Jakob Bogenberger United States
M Charon France
Shuju Feng United States
Henrik Andersen United States
Margery Rosenblatt United States
Gaylord J. Knutson United States
Isabelle Vigon
Citations per year, relative to Isabelle Vigon Isabelle Vigon (= 1×) peers Hideya Ohashi

Countries citing papers authored by Isabelle Vigon

Since Specialization
Citations

This map shows the geographic impact of Isabelle Vigon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Vigon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Vigon more than expected).

Fields of papers citing papers by Isabelle Vigon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabelle Vigon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Vigon. The network helps show where Isabelle Vigon may publish in the future.

Co-authorship network of co-authors of Isabelle Vigon

This figure shows the co-authorship network connecting the top 25 collaborators of Isabelle Vigon. A scholar is included among the top collaborators of Isabelle Vigon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabelle Vigon. Isabelle Vigon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bidet, Audrey, Amélie V. Guitart, Arnaud Villacreces, et al.. (2022). Autophagy Targeting and Hematological Mobilization in FLT3-ITD Acute Myeloid Leukemia Decrease Repopulating Capacity and Relapse by Inducing Apoptosis of Committed Leukemic Cells. Cancers. 14(2). 453–453. 6 indexed citations
2.
Dumas, Pierre‐Yves, Arnaud Villacreces, Amélie V. Guitart, et al.. (2021). Dual Inhibition of FLT3 and AXL by Gilteritinib Overcomes Hematopoietic Niche-Driven Resistance Mechanisms in FLT3 -ITD Acute Myeloid Leukemia. Clinical Cancer Research. 27(21). 6012–6025. 24 indexed citations
3.
Desplat, Vanessa, Arnaud Villacreces, Amélie V. Guitart, et al.. (2019). Targeting Tyrosine Kinases in Acute Myeloid Leukemia: Why, Who and How?. International Journal of Molecular Sciences. 20(14). 3429–3429. 34 indexed citations
4.
Naudin, Cécile, Aissa Benyoucef, Françoise Pflumio, et al.. (2017). PUMILIO/FOXP1 signaling drives expansion of hematopoietic stem/progenitor and leukemia cells. Blood. 129(18). 2493–2506. 73 indexed citations
5.
Dumas, Pierre‐Yves, Claire Drullion, Amélie V. Guitart, et al.. (2017). Chronic myeloid leukemia progenitor cells require autophagy when leaving hypoxia-induced quiescence. Oncotarget. 8(57). 96984–96992. 13 indexed citations
6.
Bodivit, Gwellaouen, et al.. (2016). Neuraminidase enhances in vitro expansion of human erythroid progenitors. European Cytokine Network. 27(2). 16–26. 1 indexed citations
7.
Pflumio, Françoise, Rima Haddad, Loïc Broix, et al.. (2012). HOXC4 homeoprotein efficiently expands human hematopoietic stem cells and triggers similar molecular alterations as HOXB4. Haematologica. 97(2). 168–178. 25 indexed citations
8.
Dimicoli‐Salazar, Sophie, et al.. (2011). Efficient in vitro myogenic reprogramming of human primary mesenchymal stem cells and endothelial cells by Myf5. Biology of the Cell. 103(11). 531–542. 4 indexed citations
9.
Callebaut, Isabelle, et al.. (2000). HYR, an extracellular module involved in cellular adhesion and related to the immunoglobulin‐like fold. Protein Science. 9(7). 1382–1390. 57 indexed citations
10.
Callebaut, Isabelle, et al.. (2000). Polydom: a secreted protein with pentraxin, complement control protein, epidermal growth factor and von Willebrand factor A domains. Biochemical Journal. 352(1). 49–49. 3 indexed citations
11.
Callebaut, Isabelle, et al.. (2000). Polydom: a secreted protein with pentraxin, complement control protein, epidermal growth factor and von Willebrand factor A domains. Biochemical Journal. 352(1). 49–59. 46 indexed citations
12.
Fichelson, Serge, Isabelle Vigon, M Charon, et al.. (1995). In vitro transformation of murine pro-B and pre-B cells by v-mpl, a truncated form of a cytokine receptor.. The Journal of Immunology. 154(4). 1577–1586. 5 indexed citations
13.
Mignotte, Vincent, et al.. (1994). Structure and Transcription of the Human c-mpl Gene (MPL). Genomics. 20(1). 5–12. 84 indexed citations
14.
Vigon, Isabelle, F. Dreyfus, J Melle, et al.. (1993). Expression of the c-mpl proto-oncogene in human hematologic malignancies. Blood. 82(3). 877–883. 79 indexed citations
15.
Vigon, Isabelle, Serge Fichelson, Guénet Jl, et al.. (1993). Characterization of the murine Mpl proto-oncogene, a member of the hematopoietic cytokine receptor family: molecular cloning, chromosomal location and evidence for a function in cell growth.. PubMed. 8(10). 2607–15. 106 indexed citations
16.
Vigon, Isabelle, et al.. (1992). Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: identification of a member of the hematopoietic growth factor receptor superfamily.. Proceedings of the National Academy of Sciences. 89(12). 5640–5644. 429 indexed citations breakdown →
18.
Coniat, Maryvonne Le, et al.. (1989). The human homolog of the myeloproliferative virus maps to chromosome band 1p34. Human Genetics. 83(2). 194–196. 26 indexed citations
19.
Wendling, Fabrice, Isabelle Vigon, Michèle Souyri, & P Tambourin. (1989). Myeloid progenitor cells transformed by the myeloproliferative leukemia virus proliferate and differentiate in vitro without the addition of growth factors.. PubMed. 3(7). 475–80. 31 indexed citations
20.
Souyri, Michèle, Isabelle Vigon, M Charon, & P Tambourin. (1989). Oncogenicity of human N-ras oncogene and proto-oncogene introduced into retroviral vectors. Journal of Virology. 63(9). 3944–3953. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026